Quick Answer
60 DEGREES PHARMACEUTICALS, INC. reported Shares Outstanding of 1.16 million shares for fiscal year 2025.
60 DEGREES PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.16M | -21.0% |
| 2025 | 1.47M | +939.1% |
| 2024 | 141,749 | -99.3% |
| 2024 | 21.22M | +21810.8% |
| 2023 | 96,847 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 4.10M | +120.4% | +178.7% |
| June 30, 2025 | 1.47M | +44.8% | +0.0% |
| March 31, 2025 | 1.47M | -87.5% | +159.8% |
| December 31, 2024 | 566,908 | +17.1% | -69.6% |
| September 30, 2024 | 1.86M | — | +83.0% |
| June 30, 2024 | 1.02M | -57.2% | -91.4% |
| March 31, 2024 | 11.76M | — | +2329.3% |
| December 31, 2023 | 484,187 | — | -79.6% |
- 60 DEGREES PHARMACEUTICALS, INC. showed a decrease of -21.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, 60 DEGREES PHARMACEUTICALS, INC.’s shares outstanding has grown by 1101.0% (from 96.8 thousand shares to 1.16 million shares).
- The most recent figure is from 60 DEGREES PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: